|
|
|
|
Vol. 303, Issue 2, 503-509, November 2002
Department of Pharmacology and Experimental Therapeutics, Kyoto
Pharmaceutical University, Misasagi, Yamashina, Kyoto, Japan (S.K.,
Y.O., K.K., M.O., K.T.); and Department of Gastroenterology, Osaka City
University Medical School, Tennoji, Osaka, Japan (T.A., T.W.)
Cyclooxygenase (COX)-2 inhibitors have been developed as new gastric
sparing anti-inflammatory drugs. We previously reported that the
ulcerogenic response to conventional nonselective COX inhibitors, such
as indomethacin and aspirin, was markedly increased in arthritic rats.
The ulcerogenic effect of selective COX-2 inhibitors in arthritic
animals, however, remains unknown. The present study was designed to
examine the influence of selective COX-2 inhibitors, such as rofecoxib
and celecoxib, on gastric mucosal integrity in rats with
adjuvant-induced arthritis. Arthritis was induced in male dark Agouti
rats by injection of Freund's complete adjuvant into the right hind
paw. Two weeks after the injection, the animals were fasted for 18 h, various COX inhibitors were administered orally, and the mucosa was
examined for lesions 4 h later. Oral administration of
indomethacin caused hemorrhagic gastric lesions in both normal and
arthritic rats, although the severity of lesions was significantly
greater in the latter group. In contrast, neither rofecoxib nor
celecoxib caused any gastric damage in normal rats, but both drugs
provoked hemorrhagic gastric lesions in arthritic rats. The expression
of COX-2 mRNA and immuno-positive cells was observed in the gastric
mucosa of arthritic but not normal rats. The gastric mucosal
prostaglandin (PG) E2 content was significantly elevated in
arthritic rats in a rofecoxib-sensitive manner. In conclusion, COX-2
inhibitors produce gastric lesions in arthritic rats, similar to the
nonselective COX-inhibitors. COX-2 is up-regulated in the stomach of
arthritic rats, and PGs produced by COX-2 play a role in maintaining
the integrity of the gastric mucosa.
This article has been cited by other articles:
![]() |
O. T. Starodub, E. S. Demitrack, H. K. Baumgartner, and M. H. Montrose Disruption of the Cox-1 gene slows repair of microscopic lesions in the mouse gastric epithelium Am J Physiol Cell Physiol, January 1, 2008; 294(1): C223 - C232. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takeuchi, A. Tanaka, S. Kato, E. Aihara, and K. Amagase Effect of (S)-4-(1-(5-Chloro-2-(4-fluorophenyoxy)benzamido)ethyl) Benzoic Acid (CJ-42794), a Selective Antagonist of Prostaglandin E Receptor Subtype 4, on Ulcerogenic and Healing Responses in Rat Gastrointestinal Mucosa J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 903 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
H K Baumgartner, O T Starodub, J S Joehl, L Tackett, and M H Montrose Cyclooxygenase 1 is required for pH control at the mouse gastric surface Gut, December 1, 2004; 53(12): 1751 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takeeda, M. Yamato, S. Kato, and K. Takeuchi Cyclooxygenase Isozymes Involved in Adaptive Functional Responses in Rat Stomach after Barrier Disruption J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 713 - 719. [Abstract] [Full Text] [PDF] |
||||